U.S. flag

An official website of the United States government

NM_003361.4(UMOD):c.816C>A (p.Tyr272Ter) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Aug 31, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000578929.4

Allele description [Variation Report for NM_003361.4(UMOD):c.816C>A (p.Tyr272Ter)]

NM_003361.4(UMOD):c.816C>A (p.Tyr272Ter)

Gene:
UMOD:uromodulin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p12.3
Genomic location:
Preferred name:
NM_003361.4(UMOD):c.816C>A (p.Tyr272Ter)
HGVS:
  • NC_000016.10:g.20348485G>T
  • NG_008151.1:g.9231C>A
  • NM_001008389.3:c.816C>A
  • NM_001278614.2:c.915C>A
  • NM_001378232.1:c.816C>A
  • NM_001378233.1:c.816C>A
  • NM_001378234.1:c.816C>A
  • NM_001378235.1:c.816C>A
  • NM_001378237.1:c.816C>A
  • NM_003361.4:c.816C>AMANE SELECT
  • NP_001008390.1:p.Tyr272Ter
  • NP_001265543.1:p.Tyr305Ter
  • NP_001365161.1:p.Tyr272Ter
  • NP_001365162.1:p.Tyr272Ter
  • NP_001365163.1:p.Tyr272Ter
  • NP_001365164.1:p.Tyr272Ter
  • NP_001365166.1:p.Tyr272Ter
  • NP_003352.2:p.Tyr272Ter
  • NC_000016.9:g.20359807G>T
  • NM_003361.2:c.816C>A
  • NR_165456.1:n.1041C>A
Protein change:
Y272*
Links:
dbSNP: rs141383844
NCBI 1000 Genomes Browser:
rs141383844
Molecular consequence:
  • NR_165456.1:n.1041C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001008389.3:c.816C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001278614.2:c.915C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001378232.1:c.816C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001378233.1:c.816C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001378234.1:c.816C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001378235.1:c.816C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001378237.1:c.816C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_003361.4:c.816C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000681209GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Dec 8, 2017)
germlineclinical testing

Citation Link,

SCV002936928Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 31, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV000681209.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The Y272X variant in the UMOD gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay, however, loss-of-function is not a known mechanism of disease for the UMOD gene. The Y272X variant is observed in 3/270,990 total alleles in large population cohorts (Lek et al., 2016). We interpret Y272X as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002936928.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 489216). This variant has not been reported in the literature in individuals affected with UMOD-related conditions. This variant is present in population databases (rs141383844, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Tyr272*) in the UMOD gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in UMOD cause disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024